Icotrokinra, a targeted oral peptide that selectively binds the interleukin-23 receptor, is under investigation for the ...

ZORYVE foam 0.3% was safe, well-tolerated, and demonstrated durable and continuously improving efficacy in the treatment of seborrheic dermatitis ...

Results of a meta-analysis showed that all biologic agents were superior to placebo for improving short-term outcomes in moderate to severe plaque psoriasis.

PSORIASIS is no longer regarded as a single, uniform condition. Once classified primarily by visible lesions or severity, it ...

Every year on 29 October, World Psoriasis Day raises awareness of the 125 million people worldwide living with PsA ...

A Collaboration with the Kids Research Institute, Octave Bioscience, and Cytokind Quantifies the Benefits of Phototherapy for Multiple Sclerosis Patients INTERVALE, N.H., Oct. 28, 2025 /PRNewswire/ -- ...

This chronic disease, which results in red, scaly and bleeding patches, can significantly affect patients' emotional well-being and self esteem.

Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing ...

Subgroup analyses from one of the agent's pivotal trials showed that 29.5% of adolescents receiving icotrokinra achieved PASI 100, reflecting 100% improvement on the Psoriasis Area and Severity Index, ...

New long-term data of the investigational therapy icotrokinra show that it is able to achieve site-specific clear or almost clear skin in patients with plaque psoriasis, according to results of the ...

The Heritage Restaurant Group is acquiring the Newport seafood restaurant Scales & Shells. The restaurant will continue its current operations through the end of the year. The current management team ...

A Reddit user has sparked a viral mystery after discovering a significant discrepancy in their weight when using two different smart scales—prompting a lively ...